Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation
2014
Dermatological aspects of a successful introduction and continuation of alcohol-based hand rubs for hygienic hand disinfection
2003
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates
2018
Use of iron oxide nanomaterials in wastewater treatment: A review
2012 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Activation and Habituation in Olfaction—An fMRI Study
2001
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm
2009
Systemic sclerosis
2017 Standout
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Porphyrias
2010 Standout
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Multimodal MRI contrast agents
2007
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging
2015
Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies
2019
Dissociation of Neural Representation of Intensity and Affective Valuation in Human Gustation
2003 Standout
Dermatologic Conditions Seen in End‐Stage Renal Disease
2009
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Acute kidney injury
2019 Standout
Applications of advanced hybrid organic–inorganic nanomaterials: from laboratory to market
2011 Standout
Stress and Rest Dynamic Myocardial Perfusion Imaging by Evaluation of Complete Time-Attenuation Curves With Dual-Source CT
2010
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
MRI contrast agents: Basic chemistry and safety
2012
High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration
2015
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition
2009
Impact of Oxidative Stress on the Heart and Vasculature
2017
Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles
2010
Extracellular Superoxide Dismutase Is a Growth Regulatory Mediator of Tissue Injury Recovery
2008
Nanomaterials: Applications in Cancer Imaging and Therapy
2011
Loss of Olfactory Function Leads to a Decrease of Trigeminal Sensitivity
1996
Complement
2001 Standout
Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus
2016
Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents
2011
Versatile PEG-derivatized phosphine oxide ligands for water-dispersible metal oxide nanocrystals
2007
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
2007 Standout
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Stabilisation of atherosclerotic plaques
2011
Nano‐Sized CT Contrast Agents
2013
Kidney injury molecule-1
2010
Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
2011
Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure
2012
epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2007
Nano-magnetite (Fe3O4) as a support for recyclable catalysts in the development of sustainable methodologies
2013 Standout
DLS and zeta potential – What they are and what they are not?
2016 Standout
SOD3 Reduces Inflammatory Cell Migration by Regulating Adhesion Molecule and Cytokine Expression
2009
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
2011 Standout
Prospects of Colloidal Nanocrystals for Electronic and Optoelectronic Applications
2009 Standout
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Maghemite Nanoparticles Protectively Coated with Poly(ethylene imine) and Poly(ethylene oxide)-block-poly(glutamic acid)
2006
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice
2018
Multifunctional Tumor pH-Sensitive Self-Assembled Nanoparticles for Bimodal Imaging and Treatment of Resistant Heterogeneous Tumors
2014
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Nociceptive and reflexive responses recorded from the human nasal mucosa
1993
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections
1990
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Polymeric Nanostructures for Imaging and Therapy
2015
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
2008
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hydrogen Autotransfer in the N-Alkylation of Amines and Related Compounds using Alcohols and Amines as Electrophiles
2009 Standout
Magnetic Nanocomposites: A New Perspective in Catalysis
2010
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Processing of Iron Oxide Nanoparticles by Supercritical Fluids
2008
Fiber-Optic Chemical Sensors and Biosensors
2006 Standout
The PREDICT Study: A Randomized Double-Blind Comparison of Contrast-Induced Nephropathy After Low- or Isoosmolar Contrast Agent Exposure
2008
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents.
2007
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
2007
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized Nanoparticles
2010 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Superparamagnetic iron oxide as an efficient catalyst for the one-pot, solvent-free synthesis of α-aminonitriles
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy
2017 Standout
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018
Polyethylene glycol-covered ultra-small Gd2O3nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning
2007
Works of Hubertus Pietsch being referenced
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
2016
How to improve instrument disinfection by ultrasound
2001
Retention of Iodine and Expression of Biomarkers for Renal Damage in the Kidney After Application of Iodinated Contrast Media in Rats
2009
The Role of Residual Gadolinium in the Induction of Nephrogenic Systemic Fibrosis-Like Skin Lesions in Rats
2010
Thermoablation of Malignant Kidney Tumors Using Magnetic Nanoparticles: An In Vivo Feasibility Study in a Rabbit Model
2009
The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis – A mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide
2009
Impact of Renal Impairment on Long-Term Retention of Gadolinium in the Rodent Skin Following the Administration of Gadolinium-Based Contrast Agents
2009
Deficiency of the Eighth Component of Complement. Evidence for Linkage of C8α‐γ Pattern with C8β Deficiency in Sera of Twelve Patients
1989
Dynamic Contrast-Enhanced Computed Tomography to Assess Antitumor Treatment Effects
2013
Kallmann's syndrome and chemosensory evoked potentials
1991
A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast Media
2007
Hand antiseptics: rubs versus scrubs, alcoholic solutions versus alcoholic gels
2001
Extracellular Superoxide Dismutase Accelerates Endothelial Recovery and Inhibits In-Stent Restenosis in Stented Atherosclerotic Watanabe Heritable Hyperlipidemic Rabbit Aorta
2007
Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue
2016
Gadolinium‐based contrast agents and NSF: Evidence from animal experience
2009
Quantitative Whole Heart Stress Perfusion CT Imaging as Noninvasive Assessment of Hemodynamics in Coronary Artery Stenosis
2010
Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents
2009
Gadolinium‐based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: The role of excess ligand
2008
Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions
2008
Viscosity of iodinated contrast agents during renal excretion
2011
In Vivo Monitoring of Angiogenesis Inhibitory Treatment Effects by Dynamic Contrast-Enhanced Computed Tomography in a Xenograft Tumor Model
2009
Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents
2017
Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
2017
Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging
2004